Evidence from preclinical and clinical studies shows that VEGF, as a predominant angiogenic factor in human cancers, plays a vital role in the carcinogenesis pathway, which has been proved to be a key step in tumor occurrence, progression and prognosis [12], [45]. The gene discussed is VEGFA; the disease is neoplasm.